CUV 0.00% $13.96 clinuvel pharmaceuticals limited

Ann: Change to executive management, page-3

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 31 Posts.
    lightbulb Created with Sketch. 10
    The choice to appoint Peter Vaughan appears to be a commendable move. It seems like Peter Vaughan has experience in IPO listings, share registries, etc. Accordingly, his expertise could play a pivotal role in steering Clinuvel toward an upgraded US ADR listing. Currently, Clinuvel resides on the pink sheets in the US. By upgrading their listing, Clinuvel could attract a fresh wave of investor interest and capital as well as dramatically increased trading volume. It is an essential and inevitable move for the Company in my opinion.
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.